Enhancing breast cancer screening with urinary biomarkers and Random Forest supervised classification: A comprehensive investigation E Alladio, F Trapani, L Castellino, M Massano, D Di Corcia, A Salomone, ... Journal of Pharmaceutical and Biomedical Analysis 244, 116113, 2024 | | 2024 |
A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on … V Bossuyt, E Provenzano, WF Symmans, F Webster, KH Allison, C Dang, ... Histopathology 84 (7), 1111-1129, 2024 | 1 | 2024 |
About uncertainty in IBD histological diagnosis G Canavese, A Sapino, R Suriani, R Rocca, M Daperno, P Cassoni, ... | | 2024 |
Quantifying mRNA in Highly Degraded Fixed Tissues by Nanostring Technology: A Comparative Study E Azzalini, B Di Stefano, V Canzonieri, T Venesio, U Miglio, C Marchiò, ... Methods and Protocols 7 (3), 40, 2024 | | 2024 |
Growth hormone-releasing hormone (GHRH) antagonists enhance radiosensitivity in non-small cell lung cancer cells I Gesmundo, F Pedrolli, GF Romana, A Bertoldo, V Gregorc, A Sapino, ... Endocrine Abstracts 99, 2024 | | 2024 |
40P A peculiar chromosome 17 copy number profile stratifies HER2-low breast carcinomas SE Bellomo, E Berrino, L Casorzo, I Sarotto, C Parlato, S Guarrera, ... ESMO Open 9, 2024 | | 2024 |
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2a Scaffolding Function Federico Gulluni, 1, 14 Miriam Martini, 1, 14,* Maria Chiara De Santis, 1 … M Compagno, S Sigismund, F Montemurro, M Thelen, F Fan, P Meraldi, ... | | 2024 |
High clonal diversity and spatial genetic admixture in early prostate cancer and surrounding normal tissue N Zhang, L Harbers, M Simonetti, C Diekmann, Q Verron, E Berrino, ... Nature Communications 15 (1), 3475, 2024 | | 2024 |
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma E Morelli, M Johnstone, M Turi, MK Samur, C Botta, S Cifric, P Folino, ... Blood, 2024 | 1 | 2024 |
Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of stage III colon cancer patients A Kudriavtsev, A Mirandola, CI Cofre Muñoz, RC Navarro, M Macagno, ... Cancer Research 84 (6_Supplement), 1026-1026, 2024 | | 2024 |
Abstract P24: GABARAP deficiency drives resistance to immunogenic chemotherapy in multiple myeloma M Turi, E Morelli, M Johnstone, MK Samur, C Botta, S Cifric, P Folino, ... Blood Cancer Discovery 5 (2_Supplement), P24-P24, 2024 | | 2024 |
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer LW de Boo, K Jóźwiak, ND Ter Hoeve, PJ van Diest, M Opdam, Y Wang, ... ESMO open 9 (3), 102923, 2024 | | 2024 |
Multicancer screening test based on the detection of circulating non haematological proliferating atypical cells N Malara, ML Coluccio, F Grillo, T Ferrazzo, NC Garo, G Donato, ... Molecular Cancer 23 (1), 32, 2024 | | 2024 |
Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update G Roccuzzo, E Bongiovanni, L Tonella, V Pala, S Marchisio, A Ricci, ... Expert Review of Molecular Diagnostics, 1-18, 2024 | 2 | 2024 |
Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR) I Ellis, F Webster, KH Allison, C Dang, H Gobbi, J Kulka, SR Lakhani, ... Histopathology, 2024 | | 2024 |
Alternative tissue fixation protocols dramatically reduce the impact of DNA artifacts, unraveling the interpretation of clinical comprehensive genomic profiling E Berrino, SE Bellomo, A Chesta, P Detillo, A Bragoni, A Gagliardi, ... Laboratory Investigation 104 (1), 100280, 2024 | 2 | 2024 |
Glyoxal acid-free (GAF) histological fixative is a suitable alternative to formalin: results from an open-label comparative non-inferiority study A Ryska, A Sapino, S Landolfi, IS Valero, SRY Cajal, P Oliveira, P Detillo, ... Virchows Archiv, 1-10, 2023 | 3 | 2023 |
Implementation of Precision Oncology in the National Healthcare System: A Statement Proposal Endorsed by Italian Scientific Societies G Fasola, MC Barducci, VD Tozzi, L Cavanna, S Cinieri, F Perrone, ... JCO Precision Oncology 7, e2300166, 2023 | | 2023 |
The silencing of the L1-MET chimeric transcript activates cancer cell death program and inhibits the expression of crucial oncoproteins in lung cancer cells U Miglio, E Berrino, D Avanzato, I Molineris, V Miano, M Milan, L Lanzetti, ... | | 2023 |
TTF-1 nuclear expression: small cell carcinoma or not? Kawasaki T, Bussolati G, Sugai T A Sapino | | 2023 |